Dissecting Toxicity of Tau and β-Amyloid

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neurodegenerative Diseases

• Publication date

  2010-02-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1159/000283475PMID 20160450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Common features between diabetes mellitus and Alzheimer’s disease

  2009cited by this paper
• Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.

  2009cited by this paper
• Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease*

  2009cited by this paper
• Amyloid-beta Leads to Impaired Cellular Respiration, Energy Production and Mitochondrial Electron Chain Complex Activities in Human Neuroblastoma Cells

  2009cited by this paper
• Human but not rat amylin shares neurotoxic properties with Aβ42 in long‐term hippocampal and cortical cultures

  2008cited by this paper
• Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice

  2008cited by this paper
• Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia

  2008cited by this paper
• Animal models of Alzheimer's disease and frontotemporal dementia

  2008cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

  2005cited by this paper
• Infectious disease: Unravelling SARS lethality

  2005cited by this paper
• Conformational Abs recognizing a generic amyloid fibril epitope

  2002cited by this paper
• Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles

  2001cited by this paper
• Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

  2001cited by this paper

• Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease

  2021cites this paper
• Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

  2021cites this paper
• Atorvastatin Improves Mitochondrial Function and Prevents Oxidative Stress in Hippocampus Following Amyloid-β1–40 Intracerebroventricular Administration in Mice

  2020cites this paper
• Neuroprotective Brain-Derived Neurotrophic Factor signaling in the TAU-P301L tauopathy zebrafish model.

  2020cites this paper
• 40 Hz invisible spectral flicker and its potential use in Alzheimer's light therapy treatment

  2020cites this paper
• Melatonin affects the release of exosomes and tau-content in in vitro amyloid-beta toxicity model.

  2020cites this paper
• Two boron-containing compounds affect the cellular viability of SH-SY5Y cells in an in vitro amyloid-beta toxicity model

  2020cites this paper
• Key Peptides and Proteins in Alzheimer's Disease.

  2019cites this paper
• Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

  2018cites this paper
• The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation

  2017cites this paper
• Effects of Detraining on Ach, AchE, β-amyloid, Apolipoprotein Expression and Cognitive Function in Brain Tissue of Memory Impairment Rats

  2017cites this paper
• The contribution of transgenic and nontransgenic animal models in Alzheimer’s disease drug research and development

  2017cites this paper
• Structural Insights into the Polymorphism of Self-Assembled Amylin Oligomers

  2016cites this paper
• Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns

  2016cites this paper
• Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores

  2016cites this paper
• Multiple Targets for the Management of Alzheimer's Disease.

  2016cites this paper
• Neurodegenerative Diseases and Dementia

  2016cites this paper
• Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity*

  2014cites this paper
• Interactions between Aβ and Mutated Tau Lead to Polymorphism and Induce Aggregation of Aβ-Mutated Tau Oligomeric Complexes

  2013cites this paper
• Aging in the nervous system of Caenorhabditis elegans

  2013cites this paper
• Neuropathological correlates of cerebral multimorbidity.

  2013cites this paper
• Amyloid and tau: neither chicken nor egg but two partners in crime!

  2013cites this paper
• Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation

  2013cites this paper
• Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

  2012cites this paper
• Interaction between pathogenic proteins in neurodegenerative disorders

  2012cites this paper
• Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s disease

  2012cites this paper
• Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic States

  2011cites this paper